GENETIC SUSCEPTIBILITY TO ESTROGEN INDUCED MAMMARY CA

对雌激素诱发的乳腺CA的遗传敏感性

基本信息

  • 批准号:
    6497481
  • 负责人:
  • 金额:
    $ 32.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-04-01 至 2003-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (adapted from the investigator's abstract) The investigators have recently demonstrated that ovary-intact, but not ovariectomized, female ACI rates treated continually with near physiologic levels of the naturally occurring estrogen, 17b-estradiol (ES2), rapidly develop multiple and often invasive mammary carcinomas. More recently, they have examined induction by E2 of mammary carcinoma in F1, F2 and backcross (BC) progeny of a genetic cross between females of t he highly susceptible ACI inbred strain and males of a resistant inbred strain, Copenhagen (COP). The data from this experiment closely fit models in which susceptibility to E2 -induced mammary cancers is conferred by the dominantly acting ACI allele of a single gene, referred to as EMCA-1 (Estrogen-induced Mammary Cancer-1) Moreover, it appears that the dominantly acting COP allele of an independently segregating gene, referred to as MCS-X (Mammary cancer suppressor-X), may act to delay development of mammary carcinomas in E2 treated progeny. These data provide the first evidence that susceptibility to E2 -induced mammary cancers in any species behaves as a relatively simple Mendelian trait conferred and/or modulated through the actions of limited number of genes. Because of the well documented role of estrogens in etiology of breast cancer in humans, the ACI rat appears to represent a unique and highly relevant animal model for the study of this disease. The hypotheses underlying the research proposed herein are: 1)EMCA-1 is necessary and sufficient to confer susceptibility to E2-induced mammary cancers; and, 2. MCS-X, segregating independently from EMCA-1 suppresses susceptibility to these E2 -induced mammary cancers. Herein they propose to map within the rat genome the locations at which EMCA-1 and MCS-X reside, and confirm the roles of these putative genes as modulators of susceptibility to E2- induced mammary cancers. j They will also define the role of progesterone in the etiology of E2-induced mammary cancer development in the ACI rat strain and further validate this strain as an important animal model for the study of breast cancer.
描述:(改编自研究者摘要) 研究人员最近证明,卵巢完整,但不 卵巢切除后,女性ACI率持续接受近 生理水平的天然雌激素,17 β-雌二醇 (ES2)迅速发展成多发性和经常是浸润性的乳腺癌。 最近,他们研究了E2对乳腺癌的诱导作用 在雌性之间遗传杂交F1、F2和回交(BC)后代中 高感ACI近交系和抗性ACI近交系的雄性 近交系,哥本哈根(COP)。 这个实验的数据 拟合模型,其中对E2诱导的乳腺癌的易感性是 由单个基因的显性作用ACI等位基因赋予, 作为EMCA-1(雌激素诱导的乳腺癌-1)此外,似乎 一个独立分离基因的显性COP等位基因 一种称为MCS-X(乳腺癌抑制因子-X)的基因可能起作用, 延迟乳腺癌在E2处理的后代中的发展。 这些 数据提供了第一个证据,即对E2诱导的 任何物种的乳腺癌都表现为相对简单的孟德尔式 通过有限数量的行为赋予和/或调节的特性 基因。 由于雌激素在病因学中的作用已被充分证实 在人类乳腺癌中,ACI大鼠似乎代表了一种独特的 和高度相关的动物模型,用于研究这种疾病。 的 本文提出的研究假设是:1)EMCA-1是 必要且充分地赋予对E2诱导的乳腺癌的易感性 癌症; 2。MCS-X,与EMCA-1独立分离,抑制 对这些E2诱导的乳腺癌的易感性。 在此,他们 建议在大鼠基因组中绘制EMCA-1和 MCS-X存在,并确认这些推定基因的作用, E2诱导的乳腺癌易感性的调节剂。J他们会 还定义了孕激素在E2诱导的 ACI大鼠品系中的乳腺癌发展,并进一步验证 该品系可作为乳腺癌研究的重要动物模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES D SHULL其他文献

JAMES D SHULL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES D SHULL', 18)}}的其他基金

Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk Locus
Emca4(8q24 乳腺癌风险基因座的大鼠直系同源物)的表征
  • 批准号:
    9311738
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk Locus
Emca4(8q24 乳腺癌风险基因座的大鼠直系同源物)的表征
  • 批准号:
    9442743
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
Genetic Etilogy of Renal Agenesis in the ACI Rat
ACI 大鼠肾发育不全的遗传病因学
  • 批准号:
    7037541
  • 财政年份:
    2005
  • 资助金额:
    $ 32.61万
  • 项目类别:
Genetic Etilogy of Renal Agenesis in the ACI Rat
ACI 大鼠肾发育不全的遗传病因学
  • 批准号:
    6901429
  • 财政年份:
    2005
  • 资助金额:
    $ 32.61万
  • 项目类别:
GENETIC SUSCEPTIBILITY TO ESTROGEN INDUCED MAMMARY CA
对雌激素诱发的乳腺CA的遗传敏感性
  • 批准号:
    2630789
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:
Genetic Susceptibility of Estrogen Induced Mammary Cancer
雌激素诱发乳腺癌的遗传易感性
  • 批准号:
    8071575
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:
Genetic Susceptibility of Estrogen Induced Mammary Cancer
雌激素诱发乳腺癌的遗传易感性
  • 批准号:
    7647984
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:
GENETIC SUSCEPTIBILITY TO ESTROGEN INDUCED MAMMARY CA
对雌激素诱发的乳腺CA的遗传敏感性
  • 批准号:
    6412740
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:
GENETIC SUSCEPTIBILITY TO ESTROGEN INDUCED MAMMARY CA
对雌激素诱发的乳腺CA的遗传敏感性
  • 批准号:
    2872021
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:
Genetic Susceptibility of Estrogen Induced Mammary CA
雌激素诱发乳腺CA的遗传易感性
  • 批准号:
    6845263
  • 财政年份:
    1998
  • 资助金额:
    $ 32.61万
  • 项目类别:

相似海外基金

Dissecting the roles of iron and hemojuvelin in hepatocellular carcinoma
剖析铁和血幼素在肝细胞癌中的作用
  • 批准号:
    478251
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Operating Grants
Combination therapy for renal cell carcinoma using oncolytic virus G47d
使用溶瘤病毒 G47d 联合治疗肾细胞癌
  • 批准号:
    23K08752
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Preoperative molecular diagnosis with novel follicular thyroid carcinoma-specific markers using cytology and blood samples
使用细胞学和血液样本进行新型滤泡性甲状腺癌特异性标记物的术前分子诊断
  • 批准号:
    23K08060
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
肌少症的影响以及通过免疫治疗耐药机制创建新的治疗靶点对肝细胞癌的影响
  • 批准号:
    23K08106
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of transcatheter arterial embolization for controlling hypoxia in hepatocellular carcinoma
经导管动脉栓塞控制肝细胞癌缺氧的研究进展
  • 批准号:
    23K07075
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the antioxidant function of xCT in lymphatic endothelial cells and its significance in oral squamous cell carcinoma.
淋巴管内皮细胞xCT抗氧化功能分析及其在口腔鳞癌中的意义
  • 批准号:
    23K16139
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Search for therapeutic target molecules based on temporal hierarchical analysis of Oral squamous cell carcinoma and functional RNA molecules
基于口腔鳞状细胞癌和功能RNA分子的时间层次分析寻找治疗靶分子
  • 批准号:
    23K16142
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
An actionable secretory program that drives tumor progression in a genetically defined subset of lung squamous carcinoma
一种可操作的分泌程序,可驱动基因定义的肺鳞癌亚群中的肿瘤进展
  • 批准号:
    10646979
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma
开发 miR-27a* 用于治疗头颈鳞状细胞癌
  • 批准号:
    10752726
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
Investigating a new vulnerability in oral squamous cell carcinoma
研究口腔鳞状细胞癌的新脆弱性
  • 批准号:
    10714352
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了